American College of Radiology Selected as Imaging Partner for VIRUS COVID-19 Registry

June 23, 2020

American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) was selected by the Society of Clinical Care Medicine (SCCM) to serve as the overall imaging repository for the Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 Registry.

American College of Radiology notes the study aims to create a real-time registry of current ICU and hospital care patterns to allow evaluation of safety and observational effectiveness of COVID-19 practices.

In collaboration with SCCM, the ACR CRI will collect all diagnostic images for the VIRUS COVID-19 Registry, create a link between the images and clinical data collected by SCCM, and archive images to make them accessible to participating sites through combined dashboard reporting.

“We are excited to support this effort to enhance the quality, safety and effectiveness of patient care during this public health crisis,” says Etta Pisano, MD, chief research officer of the ACR. “The utilization of both clinical and imaging data is likely to be very important in monitoring and predicting the course of the COVID-19 pandemic, particularly as it affects rural America in the months ahead. The ACR is proud to be of service to the country through this effort. This study also lays the groundwork for future collaborative efforts to harness the power of bringing data together in a federated model, while allowing study participants the autonomy to determine how much data is shared.”

The registry will be essential for near-real time observational comparative effectiveness studies to learn effective treatment strategies and/or provide meaningful hypotheses for clinical trials. A dashboard tracks data on trends such as mechanical ventilation duration, ICU length of stay, ICU discharge details and the type of medical support patients receive, as well as patient demographics: gender, age and race. Underscoring the urgent demand for such a registry, VIRUS hit its first major milestone of 1,000 patients enrolled after being open just three weeks. To date, it has collected data on more than 8,500 patients from 184 healthcare sites.

“The  Society of Critical Care Medicine is proud to have the ACR CRI as a partner in the Discovery VIRUS Registry, as both organizations strive to fulfill a shared mission to improve care for patients with COVID-19 and develop strategies for future outbreaks,” said SCCM CEO David Martin, CAE. “We are finding new ways to collaborate, share data and communicate information, moving quickly under unprecedented timelines. These strong partnership are vital to our success.”

Rahul Kashyap, MBBS, MBA of Mayo Clinic in Rochester, Minnesota serves as principal investigator; along with co-principal investigators Vishakha Kumar, MD, MBA of SCCM and Allen J. Walkey, MD, MSc of Boston University.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”